Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients
Authors
Keywords
Neutrophil/lymphocyte ratio, Metastatic colorectal cancer, Bevacizumab, Systemic inflammation
Journal
MEDICAL ONCOLOGY
Volume 31, Issue 9, Pages -
Publisher
Springer Nature
Online
2014-08-22
DOI
10.1007/s12032-014-0166-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells
- (2014) Angelamaria Rizzo et al. CARCINOGENESIS
- An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]
- (2013) Stephen Clarke et al. BMC CANCER
- Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer
- (2013) Wenzhuo He et al. MEDICAL ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Patients with Colorectal Cancer, Preoperative Serum Interleukin-6 Level and Granulocyte/Lymphocyte Ratio Are Clinically Relevant Biomarkers of Long-Term Cancer Progression
- (2013) Jiro Shimazaki et al. ONCOLOGY
- The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
- (2013) Aaron S. Mansfield et al. OncoImmunology
- Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
- (2012) M Scartozzi et al. BRITISH JOURNAL OF CANCER
- Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer?
- (2012) Graeme J.K. Guthrie et al. CANCER TREATMENT REVIEWS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
- (2012) Manabu Kaneko et al. ONCOLOGY
- Plasma D-Dimer Level as a Mortality Predictor in Patients with Advanced or Recurrent Colorectal Cancer
- (2012) Manabu Yamamoto et al. ONCOLOGY
- Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?
- (2012) Jessica K Dyson WORLD JOURNAL OF GASTROENTEROLOGY
- Chemoprevention of colorectal cancer in inflammatory bowel disease
- (2011) Venkataraman Subramanian et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
- (2009) Yoji Kishi et al. ANNALS OF SURGICAL ONCOLOGY
- Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model
- (2009) Munehisa Takahashi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Inflammation and cancer: how friendly is the relationship for cancer patients?
- (2009) Bharat B Aggarwal et al. CURRENT OPINION IN PHARMACOLOGY
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
- (2009) Y. Li et al. GUT
- Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer
- (2009) Mitsuru Ishizuka et al. JOURNAL OF SURGICAL ONCOLOGY
- Absolute Preoperative C-Reactive Protein Predicts Metastasis and Mortality in the First Year Following Potentially Curative Nephrectomy for Clear Cell Renal Cell Carcinoma
- (2009) T.V. Johnson et al. JOURNAL OF UROLOGY
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)
- (2008) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started